Owns and operates acute care hospitals and outpatient facilities across several urban and suburban US markets.
Owns and operates acute care hospitals and outpatient facilities across several urban and suburban US markets.
Is paid by health insurers, Medicare and Medicaid for each patient treated, with commercially insured patients paying best, so insurance mix and admission volume drive results. Equity Group Investments, the Zell family's investment firm, remains its controlling shareholder after the 2024 listing.
Moat: none (scale, regulatory licence). Local market share and certificate-of-need licensing help, but hospital care is capital- and labor-intensive with thin differentiation.
Headquarters: Nashville, Tennessee, United States · Founded: 2001 · Employees: 25,200
Size Ardent Health (ARDT) is a United States Health Care company (Hospital/Nursing Management) with a market value of $2.03B, the 1765th largest of 3,085 United States companies the cockpit tracks. Shares closed at $14.40 on 18 Nov 2026.
Performance Over six months the shares gained 52.4%, against -0.6% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue grew 2.0% over the last twelve months (peer median +8.7%); the operating margin is 5.2% (peer median 10.8%).
Valuation It trades at 11.9× forward earnings against a peer median of 35.5× (cheapest of 19).
Price implies For today's price to make sense, revenue must grow about -2% a year for seven years (Req g). Recent delivered growth is +9%, so the hurdle is -10 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 0.5 points above its cost of capital (6.7% WACC).
Short interest Short interest is 2.5% of the free float (30 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $6.45B | $6.32B | $5.97B | $5.41B | $5.13B |
| Revenue growth | — | +6% | +10% | +5% | — |
| Gross profit | $994M | $973M | $902M | $668M | $665M |
| EBITDA | $503M | $481M | $552M | $357M | $338M |
| Net income | $146M | $136M | $210M | $53.9M | $189M |
| Free cash flow | $282M | $256M | $128M | $84.3M | -$189M |
| Capital expenditure | $200M | $212M | $188M | $137M | $151M |
| Total debt | $2.27B | $2.32B | $2.28B | $2.40B | $2.39B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Ardent Health ARDT | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% |
| HCA Healthcare HCA | $99.5B | +20% | +6% | 15% | 15.6× | 3.1% |
| Community Health Systems CYH | n/a | -34% | n/a | n/a | n/a | n/a |
| Tenet Healthcare THC | $21.6B | +45% | +6% | 17% | 13.4× | -1.4% |
| Universal Health Services UHS | $10.7B | +13% | +8% | 11% | 8.3× | -1.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ARDT | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +18.8% | +1.7% | 2nd highest of 21 |
| 6-month return | +52.4% | -0.6% | 2nd highest of 21 |
| Distance from 52-week high | -22.5% | -16.9% | 8th lowest of 21 |
| Revenue growth (TTM) | +2.0% | +8.7% | 5th lowest of 21 |
| Operating margin | 5.2% | 10.8% | 5th lowest of 21 |
| Forward P/E | 11.9× | 35.5× | cheapest of 19 |
| Growth the price implies (Req g, 7 yrs) | -1.7% | 12.7% | 2nd least demanding of 16 |
| Growth delivered (Del g) | +8.7% | +10.2% | 7th lowest of 16 |
| Hurdle (Req g minus delivered) | -10.4 pp | +3.4 pp | 2nd least demanding of 16 |
| ROIC minus cost of capital | +0.5 pp | -2.7 pp | 8th highest of 21 |
| EV / EBITDA | 7.8× | 14.9× | cheapest of 14 |
| Net debt / EBITDA | 3.0× | 2.2× | 8th most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Ardent Health ARDT | United States | $2.03B | +52% | +2% | 5% | 11.9× | -1.7% | +8.7% |
| Brookdale Senior Living BKD | United States | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% | -1.4% |
| Extendicare EXE.TO | Canada | $1.91B | -16% | +36% | 9% | 19.3× | 10.8% | +8.5% |
| Huaxia Eye Hospital 301267.SZ | China | $1.78B | -18% | +2% | 15% | 23.5× | 2.1% | +10.4% |
| Topchoice Medical 600763.SS | China | $2.33B | -12% | +7% | 26% | 24.8× | 12.4% | +6.9% |
| Sienna Senior Living SIA.TO | Canada | $1.58B | -8% | +15% | 10% | 40.9× | 18.9% | +8.6% |
| Xi'an International Medical Investment 000516.SZ | China | $1.46B | -2% | -1% | -2% | n/a | 12.7% | +20.6% |
| Aevis Victoria AEVS.SW | Switzerland | $1.43B | +8% | +15% | -6% | 106.8× | 26.5% | +10.2% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.37B | -7% | +23% | 22% | 40.4× | 30.7% | +21.2% |
| Sanbo Hospital Management 301293.SZ | China | $1.35B | -29% | +17% | 6% | 135.5× | n/a | n/a |
| Spire Healthcare SPI.L | United Kingdom | $1.31B | +11% | +2% | 8% | 25.1× | 10.0% | +11.4% |
| National HealthCare NHC | United States | $3.16B | +1% | +6% | 0% | n/a | 6.4% | +9.7% |
| Raffles Medical BSL.SI | Singapore | $1.23B | -13% | -3% | 11% | 27.1× | -2.7% | +6.1% |
| CVS CVSG.L | United Kingdom | $1.22B | +17% | +6% | 11% | 14.6× | 14.2% | +6.9% |
| Krishna Institute of Medical Sciences KIMS.NS | India | $3.41B | +2% | +35% | 11% | 81.9× | n/a | n/a |
| Surgery Partners SGRY | United States | $3.53B | +100% | +2% | 13% | 77.2× | 15.6% | +12.2% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.13B | +31% | +50% | 16% | 49.4× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.10B | -4% | +21% | 21% | 30.6× | 22.1% | +10.2% |
| Rhon-klinikum RHK.DE | Germany | $1.06B | +15% | +4% | -51% | 22.5× | n/a | n/a |
| Jupiter Life Line Hospitals JLHL.NS | India | $1.01B | +9% | +17% | 16% | 48.8× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $1.01B | +2% | +11% | 20% | 20.1× | 2.3% | +19.7% |